Monoclonal antibody boom: which region administers the most – RB
Hello, Welcome to the RockedBuzz News site! I will present you all the details of Monoclonal antibody boom: which region gives more – RB here.
Monoclonal antibody boom: which region administers more – RB
Monoclonal antibody boom: which region administers the most – RB We have explained the details of the news, step by step, below. Monoclonal antibody boom: which region administers the most – RB Keep reading our news. Here are all the details on the subject.
Monoclonal antibody boom: which region administers the most – RB
There is good news regarding the use of monoclonal therapies in Italy, which is being talked about these days due to the positivity of the professor Massimo Galli . The Covid expert explained that he contracted the virus due to the highly contagious Omicron variant, despite the three doses of vaccine and the great attention paid in social contexts. The former head physician of the Sacco Hospital in Milan reported that he was also treated with monoclonal antibodies .
How much are monoclonal antibodies really used in Italy
As reported by the 40 th report of the Aifa on the use of monoclonal antibodies against Covid in Italy, in the last 7 days the requests for the drug increased by more than 11%, for a total of 32. 513 from 10 March, when these medicines are been authorized in an emergency in our country, after the positive opinion of the EMA or the national drug agency alone.
I am currently 241 the structures, throughout the national territory, which have prescribed this type of therapy, with more than 32 thousand patients treated as follows.
15. 538 patients with a mix of bamlanivimab and etesevimab antibodies. 15. 124 patients with a mix of casirivimab and imdevimab antibodies. 1. 028 patients with sotrovimab. 823 patients with bamlanivimab alone.
Which regions administer more an anti Covid monoclonal ticbodies
It is the Veneto that leads the ranking of the regions where monoclonal antibodies have been used the most, with almost 6 thousand patients treated with monoclonal antibodies. Below is the complete list.
Veneto – 5. 929 patients. Lazio – 4. 739 patients. Tuscany – 3. 860 patients. Lombardy – 2. 571 patients. Emilia Romagna – 2. 200 patients. Liguria – 2. 166 patients. Campania – 1. 823 patients. Piedmont – 1. 695 patients. Sicily – 1. 589 patients. Marche – 1. 316 patients. Puglia – 1. 050 patients. Abruzzo – 1. 048 patients. Friuli Venezia Giulia – 903 patients. Calabria – 408 patients. Aosta Valley – 389 patients. Umbria – 299 patients. Basilica – 149 patients. Sardinia – 130 patients. Trento – 126 patients. Molise – 64 patients. Bolzano – 62 patients. As can be seen from this list, the regions most affected and with the most hospitalizations are not necessarily those that make the most recourse to these medicines, considering that they cannot be administered to all types of patients.
Covid, because it is important to administer more monoclonal antibodies
However, the absolute numbers at the national level of the administration of these drugs for the treatment and prevention of severe forms of Covid. These are medicines subject to a limited medical prescription, to be renewed from time to time, and sold to the public on prescription from hospital centers identified by the Regions and Autonomous Provinces.
Monoclonal antibodies are subjected to monitoring additional , in order to quickly identify new safety information. Healthcare professionals, after administration, must report any suspected adverse reactions.
The fact that the use of these drugs is growing so much in Italy is therefore a good sign , because it allows to understand how treatments with monoclonal antibodies fight the coronavirus Spike protein, evaluate better risks and effectiveness , and establish a viable therapy to end the pandemic.
Together with monoclonal antibodies, the Merck pill is now available in Italy, as anticipated here, which could prove to be a trusted ally to defeat the disease in the early stages in subjects at risk and avoid the long and expensive hospitalizations in intensive care, which we talked about here. This new anti Covid vaccine is also arriving, also produced in Italy.
